Aptorum Group Limited (NASDAQ:APM) Short Interest Update

by · The Markets Daily

Aptorum Group Limited (NASDAQ:APM – Get Free Report) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 11,100 shares, a decrease of 41.3% from the November 30th total of 18,900 shares. Based on an average trading volume of 41,300 shares, the short-interest ratio is presently 0.3 days. Currently, 0.5% of the company’s stock are sold short.

Aptorum Group Stock Performance

Shares of NASDAQ:APM opened at $1.08 on Friday. The stock’s fifty day simple moving average is $1.01 and its two-hundred day simple moving average is $2.40. Aptorum Group has a 1-year low of $0.46 and a 1-year high of $17.49.

Aptorum Group Company Profile

(Get Free Report)

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.

Featured Stories